Created in 2015 (United States), SERES THERAPEUTICS own 2 sister brands and 2214 competing brands. SERES THERAPEUTICS is owned by SERES THERAPEUTICS COM USD0.001, listed on the stock exchange of New York SERES THERAPEUTICS belongs to the Biotechnology business sector.

SERES THERAPEUTICS is a brand of SERES THERAPEUTICS COM USD0.001 (MCRB) Share price

International deposit : 2015 Business sector Biotechnology

Share price and profitability of the share SERES THERAPEUTICS COM USD0.001 (SERES THERAPEUTICS)

Buy SERES THERAPEUTICS COM USD0.001 share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 0.72

Portfolio valuation
SERES THERAPEUTICS COM USD0.001 (SERES THERAPEUTICS) over 5 years* USD 0.08

Stock market history SERES THERAPEUTICS COM USD0.001 (SERES THERAPEUTICS)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
SERES THERAPEUTICS COM USD0.001

See more brands of SERES THERAPEUTICS COM USD0.001

Rival brands
SERES THERAPEUTICS

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS